HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean Charles Soria Selected Research

dabrafenib

1/2018Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean Charles Soria Research Topics

Disease

20Neoplasms (Cancer)
01/2020 - 05/2004
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2020 - 07/2007
4Proteinuria
11/2014 - 01/2010
3Melanoma (Melanoma, Malignant)
03/2018 - 03/2007
3Lung Neoplasms (Lung Cancer)
05/2014 - 09/2005
3Carcinoma (Carcinomatosis)
07/2012 - 03/2005
3Carcinogenesis
08/2008 - 05/2004
2Disease Progression
01/2018 - 05/2004
2Hypertension (High Blood Pressure)
11/2014 - 03/2010
2Kidney Diseases (Kidney Disease)
11/2014 - 01/2010
2Diarrhea
06/2013 - 03/2007
2Fatigue
06/2013 - 03/2007
2Thrombotic Microangiopathies
03/2010 - 01/2010
2Prostatic Neoplasms (Prostate Cancer)
12/2006 - 05/2004
1COVID-19
01/2020
1Anaplastic Thyroid Carcinoma
01/2018
1Renal Insufficiency (Renal Failure)
09/2013
1Febrile Neutropenia
06/2013
1Neutropenia
06/2013
1Thrombocytopenia (Thrombopenia)
06/2013
1Breast Neoplasms (Breast Cancer)
05/2013
1Sarcoma (Soft Tissue Sarcoma)
05/2013
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2013
1Adenocarcinoma
01/2013
1Sudden Death
12/2011
1Cardiotoxicity
12/2011
1Necrosis
03/2010
1Hypophosphatemia
03/2010
1Neoplasm Metastasis (Metastasis)
08/2008
1Colonic Neoplasms (Colon Cancer)
08/2008
1Renal Cell Carcinoma (Grawitz Tumor)
03/2007
1Alopecia (Baldness)
03/2007
1Nausea
03/2007
1Ewing Sarcoma (Sarcoma, Ewing)
12/2006
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2006
1Large Cell Carcinoma
09/2005
1Metaplasia
03/2005
1Carcinoma in Situ
03/2005

Drug/Important Bio-Agent (IBA)

4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2014 - 01/2010
4Pharmaceutical PreparationsIBA
11/2014 - 03/2007
3Proteins (Proteins, Gene)FDA Link
01/2010 - 03/2005
2LigandsIBA
11/2020 - 03/2013
2Immune Checkpoint InhibitorsIBA
11/2020 - 03/2018
2Phosphotransferases (Kinase)IBA
12/2011 - 01/2005
2Sorafenib (BAY 43-9006)FDA Link
01/2010 - 03/2007
2Aquaporin 5IBA
08/2008 - 05/2008
1Progesterone Receptors (Progesterone Receptor)IBA
01/2019
1Hormones (Hormone)IBA
01/2019
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
03/2018
1dabrafenibIBA
01/2018
1trametinibIBA
01/2018
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2018
1Antihypertensive Agents (Antihypertensives)IBA
11/2014
1Cisplatin (Platino)FDA LinkGeneric
05/2014
1Immunomodulating AgentsIBA
01/2014
1Cadherins (E-Cadherin)IBA
06/2013
1VimentinIBA
06/2013
1CrizotinibIBA
06/2013
1PM 00104IBA
06/2013
1Lipase (Acid Lipase)FDA Link
06/2013
1AVE1642IBA
05/2013
1Biological ProductsIBA
03/2013
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
03/2013
1Phosphatidylinositols (Phosphatidylinositol)IBA
01/2013
1TOR Serine-Threonine KinasesIBA
01/2013
1Angiogenesis InhibitorsIBA
12/2011
1monooxyethylene trimethylolpropane tristearate (MTTS)IBA
12/2011
1Tyrosine (L-Tyrosine)FDA Link
12/2011
1ElectrolytesIBA
03/2010
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
03/2010
1Sunitinib (Sutent)FDA Link
01/2010
1Bevacizumab (Avastin)FDA Link
01/2010
1afliberceptIBA
01/2010
1pazopanibFDA Link
01/2010
1nephrinIBA
01/2010
1Axitinib (AG 013736)IBA
01/2010
1Aquaporins (Water Channels)IBA
08/2008
1Threonine (L-Threonine)FDA Link
08/2008
1Retinoblastoma ProteinIBA
08/2008
1Mitogen-Activated Protein Kinase 3IBA
08/2008
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
08/2008
1Serine (L-Serine)FDA Link
08/2008
1ErbB Receptors (EGF Receptor)IBA
07/2007
1Tyrosine Kinase InhibitorsIBA
07/2007
1Erlotinib Hydrochloride (CP 358,774)FDA Link
07/2007
1Biomarkers (Surrogate Marker)IBA
03/2007
1HLA-A*02:01 antigenIBA
12/2006
1Peptides (Polypeptides)IBA
12/2006
1Complementary DNA (cDNA)IBA
12/2006
1Neoplasm Antigens (Tumor Antigens)IBA
09/2005
1CytokinesIBA
09/2005
1Interferon-gamma (Interferon, gamma)IBA
09/2005
1AntigensIBA
09/2005
1Telomerase (Telomerase Reverse Transcriptase)IBA
03/2005
1Messenger RNA (mRNA)IBA
03/2005

Therapy/Procedure

7Therapeutics
01/2020 - 05/2004
6Drug Therapy (Chemotherapy)
11/2020 - 09/2005
2Immunotherapy
01/2014 - 12/2006
1Radiotherapy
07/2012
1Molecular Targeted Therapy
12/2011